Related Experiment Video
Updated: Jun 22, 2026
06:19
Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
[Intravitreal triamcinolone for diabetic macular oedema. Method and complications]
1Institutul National De Diabet Prof. Dr. N. Paulescu Bucuresti. zamfir_cristina06@yahoo.com
Oftalmologia (Bucharest, Romania : 1990)
|July 3, 2009
Summary
Diabetic macular edema, a leading cause of vision loss, is often treated with laser photocoagulation. Intravitreal triamcinolone acetonide injections are emerging as a viable therapeutic option for this condition.
Area of Science:
- Ophthalmology
- Endocrinology
- Diabetic Retinopathy Research
Context:
- Diabetic macular edema (DME) is the primary cause of visual impairment in the diabetic population.
- Macular laser photocoagulation, validated by the Early Diabetic Retinopathy Study (ETDRS), is the established gold standard treatment for DME.
- Emerging research explores alternative and adjunctive therapies for managing DME.
Purpose:
- To review the current therapeutic landscape for diabetic macular edema.
- To highlight the established efficacy of laser photocoagulation.
- To introduce intravitreal triamcinolone acetonide as a potential treatment option for DME.
Summary:
- Diabetic macular edema significantly impacts vision in diabetic patients.
- Laser photocoagulation remains the benchmark treatment, with proven benefits.
- Intravitreal injections of triamcinolone acetonide have shown promise in clinical and experimental studies for DME treatment.
Impact:
- Provides an overview of DME management strategies.
- Informs clinicians about the role of established and novel treatments.
- Contributes to the understanding of therapeutic options for preserving vision in diabetics.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...